Abstract
Hormone treatments are routinely employed with bala shark Balantiocheilos melanopterus male broodstock to stimulate the production of high-quality sperm. In the current trial, three spermiation-inducing treatments were evaluated: 20 μg/kg body weight (BW) recombinant hCG; 20 μg/kg BW [D-Ala6, Pro9, NEt]- gonadotropin-releasing hormone (GnRHa) with 20 mg/kg BW metoclopramide; and poly(lactic-co-glycolic acid) (PLGA) microparticles with slow release of 10 μg/kg BW GnRHa. A 0.9% saline AS negative control was also included. Administration of the GnRHa through the form of slow release of PLGA microparticles 24 h after treatment resulted in a significantly higher sperm volume, motility percentage, and total sperm count compared to the control. Injection of GnRHa with metoclopramide induced sperm parameters that did not differ from the control, with the exception of motility percentage. The lowest potency to induce spermiation in bala sharks was in the treatment with recombinant hCG. Both PLGA microparticles and GnRHa with metoclopramide significantly increased blood plasma concentrations of testosterone and 11-ketotestosterone compared to the control. The PLGA microparticle system with continuous release of 10 μg/kg BW GnRHa was the most effective treatment in inducing spermiation in bala sharks.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
